ANTI-ARRHYTHMIC PROPERTIES OF A NEUROLEPTIC BUTYROPHENONE, MELPERONE, IN ACUTE MYOCARDIAL-INFARCTION - A DOUBLE-BLIND TRIAL

被引：0

作者：

MOGELVANG, JC ^{[1
]}

PETERSEN, EN ^{[1
]}

FOLKE, PE ^{[1
]}

OVESEN, L ^{[1
]}

机构：

[1] AS FERROSAN, DIV RES, DK-2860 SOEBORG, DENMARK

来源：

ACTA MEDICA SCANDINAVICA | 1980年 / 208卷 / 1-2期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：61 / 64

页数：4

共 50 条

[31] CLINICAL-SIGNIFICANCE OF LIDOCAINE AND ANTI-ARRHYTHMIC DRUGS DOSAGE IN MYOCARDIAL-INFARCTION [J].

MATTA, F ;

DEMARCHI, M ;

PECCHIO, F ;

BEVILACQUA, R ;

AILLON, C ;

PICCININO, C ;

RIVA, L ;

ALVINO, A ;

ANGELINO, PF .

MINERVA CARDIOANGIOLOGICA, 1981, 29 (04) :131-136

[32] RANDOMIZED DOUBLE-BLIND CROSSOVER EVALUATION OF ORAL ACEBUTOLOL ANTI-ARRHYTHMIC EFFICACY [J].

LOW, RI ;

JOYE, JA ;

DEMARIA, AN ;

LEE, G ;

KOZINA, JA ;

MENNING, RP ;

MASON, DT .

CLINICAL RESEARCH, 1981, 29 (02) :A219-A219

[33] RANDOMIZED DOUBLE-BLIND TRIAL OF RECOMBINANT PRO-UROKINASE AGAINST STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].

MEYER, J .

LANCET, 1989, 1 (8643) :863-868

[34] A MULTICENTER DOUBLE-BLIND TRIAL AIMED AT COMPARING THE EFFICIENCY AND SAFETY OF ALTEPLASE AND ANISTREPLASE IN ACUTE MYOCARDIAL-INFARCTION [J].

BASSAND, JP ;

CASSAGNES, J ;

MACHECOURT, J ;

ANGUENOT, T ;

LUSSON, JR ;

BERNARD, B ;

VUILLEMENOT, A ;

WOLF, JE ;

VACHER, D .

CIRCULATION, 1990, 82 (04) :665-665

[35] A DOUBLE-BLIND RANDOMIZED MULTICENTER DOSE-RANGING TRIAL OF INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].

SIX, AJ ;

LOUWERENBURG, HW ;

BRAAMS, R ;

MECHELSE, K ;

MOSTERD, WL ;

BREDERO, AC ;

DUNSELMAN, PHJM ;

VANHEMEL, NM .

AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) :119-123

[36] PHARMACOKINETIC STUDY OF A NEW ANTI-ARRHYTHMIC DRUG, CIBENZOLINE, DURING THE ACUTE PHASE OF MYOCARDIAL-INFARCTION - THERAPEUTIC CORRELATIONS [J].

DESOUTTER, P ;

DUFOUR, A ;

AYMARD, MF ;

HAIAT, R .

THERAPIE, 1983, 38 (03) :237-245

[37] POTENTIATION OF THE ANTI-ARRHYTHMIC ACTION OF LIDOCAINE BY TETRODOTOXIN IN THE LATE STAGE OF EXPERIMENTAL MYOCARDIAL-INFARCTION [J].

ROZENSHTRAUKH, LV ;

ANYUKHOVSKII, EP ;

BELOSHAPKO, GG .

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1981, 91 (01) :45-48

[38] NIFEDIPINE THERAPY FOR THREATENED AND ACUTE MYOCARDIAL-INFARCTION - A RANDOMIZED DOUBLE-BLIND COMPARISON [J].

MULLER, J ;

MORRISON, J ;

STONE, P ;

RUDE, R ;

ROSNER, B ;

ROBERTS, R ;

PEARLE, D ;

TURI, Z ;

SCHNEIDER, J ;

SERFAS, D ;

HENNEKENS, C ;

BRAUNWALD, E .

CIRCULATION, 1983, 68 (04) :120-120

[39] TREATMENT OF RECURRENT VENTRICULAR-FIBRILLATION IN MYOCARDIAL-INFARCTION WITH ELECTROSTIMULATION AND ANTI-ARRHYTHMIC DRUGS [J].

PRAGER, H ;

HAIDERER, O ;

KOLLER, H ;

STERZ, H .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1981, 4 (03) :A67-A67

[40] ANTI-ARRHYTHMIC EFFICACY, PHARMACOKINETICS AND CLINICAL SAFETY OF TOCAINIDE IN CONVALESCENT MYOCARDIAL-INFARCTION PATIENTS [J].

KLEIN, MD ;

LEVINE, PA ;

RYAN, TJ .

CHEST, 1980, 77 (06) :726-730

← 1 2 3 4 5 →